The length, the composition, the quality and the characteristics of value chains essentially determine the corporate as well as the macroeconomic performance of the economic sectors and industries. Hungary has a strong tradition in the pharmaceutical industry but its dynamising impact seems to be limited on the economy. The aim of this paper is to detect and reveal the specialties of the Hungarian pharmaceutical industry both in space and time by a value chain analysis. Our method is partly quantitative, we use an input-output analysis; and partly qualitative, relying on interviews with the representatives of pharmaceutical companies. We found that the Hungarian pharma value chain is really special, having relatively short backward and forward linkages with mainly indirect value-added contribution as well as high import content of exports. However, our company interviews revealed the fundamental differences between original and generic value chains – i.e. again a pharma industry-specific distinction. Having relatively little original and more substantial generic production in Hungary explains much of the value chain specialties, which leaves its mark on the limited impact of the industry on the national economy.

中文翻译：

---

匈牙利制药价值链的特色

价值链的长度，组成，质量和特征从根本上决定着经济部门和产业的公司以及宏观经济表现。匈牙利在制药业有着悠久的传统，但其蓬勃发展的影响似乎对经济影响有限。本文的目的是通过价值链分析来发现并揭示匈牙利制药业的时空特征。我们的方法是部分定量的，我们使用投入产出分析；部分定性，取决于与制药公司代表的访谈。我们发现匈牙利的制药价值链确实很特殊，其前后联系相对较短，主要是间接的增值贡献以及较高的出口进口含量。然而，我们公司的采访揭示了原始价值链和通用价值链之间的根本区别-即，还是制药行业特定的区别。匈牙利的原始仿制产品产量相对较少，数量较多，这解释了许多价值链特色产品，这在该行业对国民经济的有限影响上留下了印记。